Human BioSystems

Human BioSystems was a biotechnology company dedicated to advancing the science of organ and tissue preservation for clinical transplantation. The company developed proprietary metabolic reduction and ice-free cryopreservation technologies intended to extend the viable storage time of donor organs, such as hearts, livers, and kidneys. By improving the logistics of organ transport and storage, Human BioSystems aimed to increase the availability of transplantable tissues and improve patient outcomes. The company focused on vitrification, a process that solidifies liquids into a glass-like state without forming damaging ice crystals. Although it was publicly traded, the company faced significant financial challenges and has since ceased active operations.